HIF1A and central nervous system cancer: HIF1α ChIP-chip binding locations have been reported in cell lines of diverse tissue origin, namely HepG2 hepatocarcinoma cells [9], MCF-7 breast cancer cells [10] and U87 glioma cells [11], showing differences in the binding sites identified in each experiment.